WASHINGTON–(BUSINESS WIRE)–#COVID19–Xlear has filed a Pre-Emergency Use Authorization (Pre-EUA) Request with the U.S. Food and Drug Administration (FDA) seeking approval to make claims that the nasal spray is approved for use in preventing SARS-CoV-2 (COVID-19) transmission and infection. The Pre-EUA is a first step in seeking formal authorization of Xlear Nasal Spray as tool to help in combatting COVID-19.
Xlear previously filed a pre-EUA seeking approval for use of the nasal spray as a medical device in combatting COVID-19. However, because the FDA determined that Xlear �works against the virus, the FDA told Xlear it would need to be considered as a drug or combination product EUA.
Seeing that the FDA says Xlear works against the virus, we have decided to seek EUA approval as a drug, said Nathan Jones, Xlears CEO.
Xlears Pre-EUA Request is based on recent studies showing the nasal spray is:
Xlear is currently sold in over 50,000 pharmacies, grocery stores, and online as a nasal spray. Xlear doesnt require the EUA to be sold and usedwe only need an EUA to be able to inform people about the benefits of using Xlear to protect themselves from COVID-19. Its insane. Without the EUA, the Federal Trade Commission wont let us simply inform people about new, published, independent scientific studies, Jones added.
We hope to move forward quickly with FDA to address gaps in current prevention and treatment strategies against SARS-CoV-2. People should be using Xlear as part of a layered defense to prevent getting COVID-19. If everyone used Xlear, in addition to taking other steps recommended by public health officials, we believe we could help the nation defeat COVID-19 faster, Jones added.
More information on Xlear: https://xlear.com/
Contacts
Jeff Gulko
617.304.7339
jeff@thegulkogroup.com
Recognized a Leader for Second Consecutive Year Based on Completeness Of Vision and Ability To…
HONG KONG SAR - Media OutReach Newswire - 7 May 2024 - Luxshare Precision, a…
ServiceNow’s AI platform for digital business, combined with Fujitsu industry expertise, will maximize value for…
WICHITA, Kan.--(BUSINESS WIRE)--Textron Aviation today announced the Cessna SkyCourier twin utility turboprop has been awarded…
HANOI, VIETNAM - Media OutReach Newswire - 7 May 2024 - VinFast Auto (Nasdaq: VFS)…
HYDERABAD, India--(BUSINESS WIRE)--$RDY #DRREDDY--Dr. Reddy’s Laboratories Ltd. (BSE: 500124 | NSE: DRREDDY | NYSE: RDY…